Medicamen Biotech Limited Stock Price

BSE:531146 Community·₹2.9b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

531146 Share Price Performance

₹230.85

-296.55 (-56.23%)

₹230.85

-296.55 (-56.23%)

₹230.85

Fri, 3 Apr 26

Share Pricen/a

531146 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with acceptable track record.

3 Risks

0 Rewards

View Full Analysis

Medicamen Biotech Limited Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 6.11
: 50.49%
: 4.51%
: 14.0%

View Full Analysis

About 531146

Founded: 1993
Employees: 376
CEO: Rajesh Madan
WebsiteView website: www.medicamen.com

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.